12777700|t|Induction of antioxidative and antiapoptotic thioredoxin supports neuroprotective hypothesis of estrogen.
12777700|a|The original neuroprotective hypothesis of estrogen was based on the gender difference in brain response to the ischemia-reperfusion injury. Additional clinical reports also suggest that estrogen may improve cognition in patients with Alzheimer disease. 17beta-Estradiol is the most potent endogenous ligand of estrogen, which protects against neurodegeneration in both cell and animal models. Estrogen-mediated neuroprotection is probably mediated by both receptor-dependent and -independent mechanisms. Binding of estrogen such as 17beta-estradiol to estrogen receptors (ERs) activates the homodimers of ER-DNA and its binding to estrogen response elements in the promoter region of genes such as neuronal nitric oxide synthase (NOS1) for regulating gene expression in target brain cells. In addition to the induction of NOS1, estrogen increases the expression of antiapoptotic protein such as bcl-2. Furthermore, our recent observations provide new molecular biologic and pharmacologic evidence suggesting that physiologic concentrations of 17beta-estradiol (<10 nM) activate ERs (ERbeta > ERalpha) and upregulate a cyclic guanosine 5'- monophosphate (cGMP)-dependent thioredoxin (Trx) and MnSOD expression following the induction of NOS1 in human brain-derived SH-SY5Y cells. We thus proposed that the estrogen-mediated gene induction of Trx plays a pivotal role in the promotion of neuroprotection because Trx is a multifunctional antioxidative and antiapoptotic protein. For managing progressive neurodegeneration such as Alzheimer dementia, our estrogen proposal of the signaling pathway of cGMP-dependent protein kinase (PKG) in mediating estrogen-induced cytoprotective genes thus fosters research and development of the new estrogen ligands devoid of female hormonal side effects such as carcinogenesis.
12777700	45	56	thioredoxin	Gene	7295
12777700	218	245	ischemia-reperfusion injury	Disease	MESH:D015427
12777700	327	335	patients	Species	9606
12777700	341	358	Alzheimer disease	Disease	MESH:D000544
12777700	360	376	17beta-Estradiol	Chemical	MESH:D004958
12777700	450	467	neurodegeneration	Disease	MESH:D019636
12777700	639	655	17beta-estradiol	Chemical	MESH:D004958
12777700	712	714	ER	Gene	2069
12777700	837	841	NOS1	Gene	4842
12777700	929	933	NOS1	Gene	4842
12777700	1002	1007	bcl-2	Gene	596
12777700	1150	1166	17beta-estradiol	Chemical	MESH:D004958
12777700	1190	1196	ERbeta	Gene	2100
12777700	1199	1206	ERalpha	Gene	2099
12777700	1225	1259	cyclic guanosine 5'- monophosphate	Chemical	-
12777700	1261	1265	cGMP	Chemical	-
12777700	1277	1288	thioredoxin	Gene	7295
12777700	1290	1293	Trx	Gene	7295
12777700	1299	1304	MnSOD	Gene	6648
12777700	1343	1347	NOS1	Gene	4842
12777700	1351	1356	human	Species	9606
12777700	1371	1378	SH-SY5Y	CellLine	CVCL:0019
12777700	1448	1451	Trx	Gene	7295
12777700	1517	1520	Trx	Gene	7295
12777700	1608	1625	neurodegeneration	Disease	MESH:D019636
12777700	1634	1652	Alzheimer dementia	Disease	MESH:D000544
12777700	1735	1738	PKG	Gene	5592
12777700	1904	1918	carcinogenesis	Disease	MESH:D063646
12777700	Negative_Correlation	MESH:D004958	MESH:D019636
12777700	Positive_Correlation	MESH:D004958	2069
12777700	Association	MESH:D000544	5592
12777700	Positive_Correlation	4842	6648
12777700	Positive_Correlation	MESH:D004958	2099
12777700	Association	MESH:D019636	5592
12777700	Association	4842	7295
12777700	Positive_Correlation	MESH:D004958	4842
12777700	Positive_Correlation	MESH:D004958	2100
12777700	Positive_Correlation	MESH:D004958	7295
12777700	Positive_Correlation	MESH:D004958	6648

